Hi friends,
Today I posted my interview with Dr. Dearden on treatment of the elderly with some interesting discussion and references on how to define age in the CLL population.
Please check out it at bkoffman.blogspot.com
I am back from traveling and will be busy catching up on a backlog of videos and news, personal and general in CLL on my blog over the next few weeks.
Stay strong
Brian
MANY thanks Brian.
This an excellent over view of CLL for the older patient from one of the UK experts in CLL.
Dr Dearden's breadth and depth of knowledge is impressive and the video needs a couple of reruns to take in all the information provided.
Dick
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)
ASH 2012 Interview: Dr Jeff Sharman \"Why New CLL Treatments Supersede FCR\"
venetoclax and obinutuzumab treatment for cll
Dr. Wierda on the paradigm shift in CLL.ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL
